JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaValve is a privately-held, venture capital backed U.S. corporation with operations in Munich, Germany. The Company's TAVI products are being sold primarily in Europe. Please visit for more information.
Company growth
München, DE
Size (employees)
58 (est)-1%
JenaValve was founded in 2006 and is headquartered in München, DE

JenaValve Office Locations

JenaValve has offices in München, Irvine
München, DE
Irvine, US

JenaValve Metrics

JenaValve Summary

Founding Date


Total Funding

$113 M

Latest funding size

$26.5 M

Time since last funding

over 1 year


We estimate that JenaValve's latest funding round in August 2015 was $26.5 M. In total, JenaValve has raised $113 M
We estimate that JenaValve's current employees are approximately 11% female and 89% male.

JenaValve Company Life

You may also be interested in